Burns J W & Co. Inc. NY boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.3% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 11,739 shares of the medical equipment provider's stock after purchasing an additional 1,649 shares during the period. Burns J W & Co. Inc. NY's holdings in Intuitive Surgical were worth $5,814,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $25,000. Hurley Capital LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth $28,000. Parvin Asset Management LLC purchased a new position in Intuitive Surgical in the 4th quarter worth $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical in the 4th quarter worth $28,000. Finally, Global Financial Private Client LLC increased its position in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, SVP Mark Brosius sold 492 shares of the company's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $554.17, for a total transaction of $272,651.64. Following the completion of the sale, the senior vice president now directly owns 3,072 shares of the company's stock, valued at approximately $1,702,410.24. This represents a 13.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 25,778 shares of company stock valued at $12,867,197. Insiders own 0.70% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on the stock. Royal Bank of Canada cut their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Piper Sandler cut their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Finally, Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $596.05.
Get Our Latest Stock Analysis on ISRG
Intuitive Surgical Stock Performance
Shares of ISRG traded up $0.95 during mid-day trading on Monday, hitting $553.29. 1,059,435 shares of the company traded hands, compared to its average volume of 1,644,201. The stock has a 50-day moving average price of $516.44 and a two-hundred day moving average price of $538.55. Intuitive Surgical, Inc. has a 1 year low of $397.47 and a 1 year high of $616.00. The stock has a market cap of $198.31 billion, a price-to-earnings ratio of 86.32, a P/E/G ratio of 5.85 and a beta of 1.70.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the previous year, the company earned $1.50 earnings per share. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.